Arati V.RaoMD

PubMed

• 120 citations
  Non-viral precision T cell receptor replacement for personalized cell therapy.
  Susan P Foy, Kyle Jacoby, Daniela A Bota, Theresa Hunter, Zheng Pan
  Nature. 2023-03-01
• 26 citations
  Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expres...
  Alison Walker, John C. Byrd, James S. Blachly, Bhavana Bhatnagar, Alice S. Mims
  Clinical Cancer Research. 2020-11-15
• 28 citations
  Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philade...
  Mark B. Geyer, Ellen K. Ritchie, Arati V. Rao, Shreya Vemuri, Jessica Flynn
  Haematologica. 2020-10-13

Journal Articles

• Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia  
  Morris TA, DeCastro CM, Diehl LF, Gockerman JP, Lagoo AS, Li Z, Moore JO, Rizzieri DA, Rao AV, Leukemia Research, 1/1/2013
• Phase I Study of Dose Dense Induction and Consolidation with Gemtuzumab Ozogamicin and High Dose Cytarabine in Older Adults with AML  
  Rao AV, Rizzieri DA, DeCastro CM, Diehl LF, Lagoo AS, Moore JO, Gockerman JP, Journal of Geriatric Oncology, 1/1/2012
• Role of pain medications, consultants, and other services in the improved pain control of elderly cancer patients in the geriatric evaluation and management units (GEM...  
  Nipp R, Sloane R, Rao AV, Schmader K, Cohen HJ, Journal of the American Geriatrics Society, 1/1/2012
• Considerations and Controversies in the Management of Older Patients with Advanced Cancer  
  Mohile SG, Klepin HD and Rao AV, American Society of Clinical Oncology Educational Handbook, 1/1/2012
• Age-associated differences in fatigue among patients with cancer  
  Butt Z, Rao AV, Lai JS., Abernethy AP, Rosenbloom S, & Cella D, Journal of Pain and Symptom Management, 1/1/2010
• Age-specific Differences in Oncogenic Pathway Dysregulation and Anthracycline sensitivity in Patients with Acute Myeloid Leukemia  
  Rao AV, Valk PJM, Metzeler KH, Acharya CR, Tuchman SA, Stevenson MM, Rizzieri DA, Delwel R, Buske C, Bohlander SK, Potti A, Lowenberg B, Journal of Clinical Oncology, 1/1/2009
• Fatigue in Older Cancer Patients: Etiology, Assessment, and Treatment  
  Rao AV and Cohen HJ, Seminars in Oncology, 1/1/2008
• Current and Emerging Strategies for the Management of Acute Myeloid Leukemia in the Elderly  
  Laubach J and Rao AV, The Oncologist, 1/1/2008
• Phase I evaluation of Gemcitabine, Mitoxantrone, and their effect on plasma disposition of Fludarabine in patients with relapsed or refractory leukemias  
  Rao AV, Younis IR, Sand JG, Spasojevic I, Adams DJ, Decastro CM, Gockerman JP, Peterson BL, Petros WP, Moore JO, Rizzieri DA, Leukemia and Lymphoma, 1/1/2008
• Monoclonal Antibodies as Targeted Therapy in Hematological Malignancies in Older Adults  
  Rao AV, Schmader K, American Journal of Geriatric Pharmacotherapy, 1/1/2007
• The Older Cancer Survivor  
  Rao AV, Demark-Wahnefried W, Critical Reviews in Oncology-Hematology, 1/1/2006
• Geriatric Evaluation and Management Units in the Care of the Frail Elderly Cancer Patient  
  Rao AV, Hsieh F, Feussner JR and Cohen HJ, Journal of Gerontology: Biological Sciences and Medical Sciences, 1/1/2005
• Radioimmunotherapy in Non-Hodgkin’s Lymphoma  
  Rao AV, Rizzieri DA, Clinical Medicine & Research, 1/1/2005
• Symptom Management in the Elderly Cancer Patient  
  Rao AV, Cohen HJ, Journal of the National Cancer Institute: Monographs, 1/1/2004
• Geriatric Assessment and Co-morbidity in Elderly Cancer Patients  
  Rao AV, Seo PH, Cohen HJ, Seminars in Oncology, 1/1/2004
• Join now to see all

Abstracts/Posters

• KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase...
  Arati V. Rao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019